Potential carcinogenicity of some transition metal ions

Biological Trace Element Research

Volumn 67, Issue 1, 1999, Pages 63-73

  Dovinova I ^a   Vachalkova A ^a   Novotny L ^b  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

DC polarography; Lipoic acid; Potential carcinogenicity; Transition metal ions

Indexed keywords

CADMIUM; COPPER; FERRIC ION; FERROUS ION; LEAD; MANGANESE; METAL; THIOCTIC ACID; VANADIUM;

ARTICLE; CARCINOGENICITY; DIFFUSION; POLAROGRAPHY; REDUCTION;

EID: 0032915081     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02784276     Document Type: Article

References (36)

1. B. Halliwell and J. M. C. Gutteridge, Oxygen toxicity, oxygen radicals, transition metals and disease, Biochem. J. 47(219), 1-14 (1984).
2. W. W. Tso and W. P. Fung, mutagenicity of metallic cations, Toxicol. Lett. 8, 195-200 (1981).
3. H. Babich, M. A. Devanas, and G. Stotzky G, The mediation of mutagenicity and clastogenicity of heavy metals by physicochemical factors, Environ. Res. 37, 253-256 (1985).
4. H. J. Issaq, Carcinogenicity and metal ions, in Metal Ions and Biological Systems, Vol. 10, H. Siegel, ed., Marcel Dekker, New York, p. 55 (1985).
5. S. Borrello, M. E. De Leo, and T. Galeotti, Defective gene expression of MnSOD in cancer cells, Mol Aspects Med, 14(3), 253-258 (1993).
6. L. Novotný and A. Vachálková, Some electrochemical characteristics of synthetic analogs of nucleic acids components I. Derivatives of cytidine and arabinosylcytosine, Neoplasma 37, 377-386 (1990).
7. V. E. Kagan and A. Shedova, Dihydrolipoic acid an universal antioxidant both in the membrane and in the aqueous phase, Biochem. Pharmacol. 44, 1637-1645 (1992).
8. L. Packer, S. Roy, and Ch. K. Sen, α-Lipoic acid a metabolic antioxidant and potential redox modulator of transcription, in Advances in Pharmacology 38, Academic, San Diego, CA, pp. 70-101 (1997).
9. W. Bunge, Eigenschaften und Reinigung der wichtigsten organischen Losungmittel, G. Thieme Verlag, Stuttgart 91959).
10. V. Podaný and A. Vachálková, Electrochemical properties of polycyclic compounds studied by polarographic method in anhydrous system, Neoplasma 20, 631 (1973).
11. A. Vachálková and L. Novotný, Some electrochemical characteristics of synthetic analogs of nucleic acids components II. Derivatives of uridine and arabinosyluracyl, Neoplasma 37, 555-563 (1990).
12. A. Vachálková, L. Novotný, A. Pískala, Polarographic reduction and carcinogenic index tg α of 5-aza nucleosides possessing antileukemic activity, Neoplasma 40, 289-292 (1993).
13. L. Novotný, A. Vachálková, and Pískala A. Polarographic reduction and potential carcinogenicity of synthetic 1,3,5-triazine bases and nucleosides, Collect. Czech Chem. Commun. 59, 1691-1698 (1994).
14. R. Meneghini, Iron homeostasis, oxidative stress, and DNA damage, Free Radical Biol Med 23, 783-792 (1997).
15. S. Toyokuni, Iron-induced carcinogenesis: the role of redox regulation, Free Radical. Biol. Med. 20, 553-566 (1996).
16. H. J. Thompson, K. Kennedy, and J. Juzefyk, Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea, Carcinogenesis 12, 111-114 (1991).
17. M. M. Jacobs and R. J. Piente, Modulation of carcinogenesis by other minerals, in Chemical Induction of Cancer, J. C. Arcos, ed., Birkhauser, Boston, pp. 349-353 (1995).
18. V. Herbert, S. Shaw, E. Jayatilleke, and T. Stopler-Kasdan, Most free radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by deferoxamine and apoferritin. Stem Cells 12, 289-303 (1994).
19. M. E. Conrad, C. Uzel, M. Berry, and L. Latour, Ironic catastrophes: one's food-another's poison. Am. J. Med. Sci. 307, 434-437 (1994).
20. M. M. Jacobs and R. J. Piente, Copper modulation of chemical carcinogenesis, in Chemical Induction of Cancer, J. C. Arcos, ed., Birkhauser, Boston, pp. 344-346 (1995).
21. E. P. Norkus, W. Kuenzig, and A. H. Cooney, Studies on the mutagenic activity of ascorbic acid in vitro and in vivo. Mutat. Res. 117, 183-191 (1983).
22. Anonymous, NTP - Technical Report on the toxicology and carcinogenesis studies of manganese (II) sulfate monohydrate in F344/N rats and B6C3F1 mice (Feed-studies). Available from National Technical Information Service, Springfield, VA as NTIS/PB94-217148 (1994).
23. Y. Sun, N. H. Colburn, and L. W. Oberley, Decreased expression of manganese super-oxiddismutase mRNA and protein after immortalization and transformation of mouse liver cells, Oncol. Res. 5(3), 127-132 (1993).
24. H. Sakurai, Vanadium distribution in rats and DNA cleavage by vanadyl complex: implication for vanadium toxicity and biological effects, Environ. Health Perspect. 102,(suppl.3), 35-36 (1994).
25. K. H. Thompson and J. H. McNeill, Effect of vanadyl sulfate feeding on susceptibility to peroxidative change in diabetic rats, Res. Commun. Chem. Pathol. Pharmacol. 80(2), 187-200 (1993).
26. T. F. Cruz, A. Morgan, and W. Min, Antineoplastic effect of vanadium compounds Proc. Annu. Meet. Am. Assoc. Cancer. Res. 36, A2357 (abstract) (1995).
27. A. M. Cortizo and S. B. Etcheverry, Vanadium derivatives act as growth factor - mimetic compounds upon differentiation and proliferation of osteoblast-like umr106 cells, Mol. Cell Biochem. 145(2), 97-102 (1995).
28. A. Columbano, T. Endoh, A. Denda, O. Noguchi, D. Nakae, K. Hasegawa, et al., Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis, Carcinogenesis 17(3), 395-400 (1996).
29. A. K. Ghoshal, The characterization of cytochrome P-450 expression during rat liver carcinogenesis, Diss. Abstr. Int. [B] 55(12), 5200 (1995).
30. P. Koo, The regulation of placental glutathione s-transferase (gst-p or -7-7) expression in rat liver in relation to chemical hepatocarcinogenesis, Diss. Abstr. Int. [B] 53(12), 6237 (1993).
31. M. P. Waalkes, B. A. Diwan, J. M. Ward, D. E. Devor, and R. A. Goyer, Renal tubular tumors and a typical hyperplasias in b6c3f1 mice exposed to lead acetate during gestation and lactation occur with minimal chronic nephropathy, Cancer Res. 55(22), 5265-5271 (1995).
32. J. P. Wise, J. M. Orenstein, and S. R. Patierno, Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake, Carcinogenesis 14(3), 429-434 (1993).
33. J. P. Wise, D. M. Stearns, Sr., K. E. Wetterhahn, and S. R. Patierno, Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis, Carcinogenesis 15(10), 2249-2254 (1994).
34. M. K. Abshire, D. E. Devor, B. A. Diwan, J. D. Shaughnessy, Jr., and M. P. Waalkes, In vitro exposure to cadmium in rat 16 myoblasts can result in both enhancement and suppression of malignant progression in vivo, Carcinogenesis 17(6), 1349-1356 (1996).
35. M. P. Waalkes, B. A. Diwan, S. Rehm, J. M. Ward, M. Moussa, M. G. Cherian, et al., Down-regulation of metallothionein expression in human and murinehepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice, J. Pharmacol. Exp. Ther. 277(2), 1026-1033 (1996).
36. J. L. Brown and K. T. Kitchin, Arsenite, but not cadmium, induces ornithine decarboxylase and heme oxygenase activity in rat liver: relevance to arsenic carcinogenesis, Cancer Lett. 98(2), 227-231 (1996).